News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Conference News TVT 2022 Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests Michael O'Riordan June 09, 2022